Riboflavin 566 views0 applications

Australian approved name (AAN): Riboflavin

Common names and synonyms: Riboflavine; Riboflavin anhydrous; Riboflavine anhydrous; Vitamin B2; 7,8-Dimethyl-10-[(2S,3S,4R)-2,3,5,5-tetrahydroxypentyl]benzo[g]pteridine-2,4(3H,10H0-dione.

Molecular formula: C17H20N4O6

Molecular weight: 376.36

RDI for Riboflavin as per NHMRC:
Infants – 0-6 months – 0.3mg/day (AI)
Infants – 7-12 months – 0.4mg/day (AI)
Children – 1-3 years – 0.5mg/day
Children – 4-8 years – 0.6mg/day
Children – 9-13 years – 0.9mg/day
Male – 14 – 70 years – 1.3mg/day
Male – >70 years – 1.6mg/day
Female – 14 -70 years – 1.1mg/day
Female – >70 years – 1.3mg/day
Pregnancy – 1.4mg/day
Lactation – 1.6mg/day

Warning and restrictions: When used as an active ingredient and the route of administration is oral or sublingual, the medicine requires the following warning statement on the medicine label:
VIT – Vitamins can only be of assistance if the dietary vitamin intake is inadequate. OR Vitamin supplements should not replace a balanced diet

Allowable purpose of the ingredient: Active. Excipient

TGA reference: British Pharmacopoeia

Apply for this resource
Share this resource

Advanced Wellness Regulatory Solutions are a team of highly skilled professionals who specialise in providing timely and reliable regulatory and research & development advice.



While we take all measures to ensure that the information provided on this site is accurate, before relying on the material in any important matter, users should carefully evaluate its accuracy, completeness and relevance for their purposes, and should obtain any appropriate professional advice relevant to their particular circumstances.


Want to stay up to date with the latest industry changes and updates? Signup to our newsletter below.